-+ 0.00%
-+ 0.00%
-+ 0.00%

Opthea's Pivotal Phase 3 Trials For Sozinibercept In Wet AMD Completes Enrollment, Topline Results Anticipated Mid-2025

Benzinga·05/28/2024 12:17:39
Listen to the news
  • Phase 3 program enrolled 1,984 patients across COAST and ShORe trials
  • Trials designed to replicate superiority in visual outcomes demonstrated in Phase 2b
  • Topline data from both pivotal trials expected in mid-CY2025